Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $202.5900 (-1.5%) ($198.5700 - $215.9000) on Fri. Oct. 12, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.47% (three month average) | RSI | 10 | Latest Price | $202.5900(-1.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -4.5% a day on average for past five trading days. | Weekly Trend | LGND declines -9.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.235% in a week (0% probabilities). VXX(-16%) TLT(-16%) VIXM(-13%) UUP(-9%) GDXJ(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.235% (StdDev 2.47%) | Hourly BBV | 0 () | Intraday Trend | -2.4% | | | |
|
Resistance Level | $252.55 | 5 Day Moving Average | $220.91(-8.29%) | 10 Day Moving Average | $239.76(-15.5%) | 20 Day Moving Average | $252.55(-19.78%) | To recent high | -26.2% | To recent low | 0% | Market Cap | $3.256b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |